Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat

A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks

NCT07009262 ·Status: COMPLETED

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

NCT06679881 ·Status: RECRUITING ·Phase: PHASE3

A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema

NCT05695248 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema

NCT02870972 ·Status: COMPLETED ·Phase: PHASE2

NTLA-2002 in Adults With Hereditary Angioedema (HAE)

NCT05120830 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)

NCT06690047 ·Status: COMPLETED ·Phase: PHASE4

Berotralstat Treatment in Children With Hereditary Angioedema

NCT05453968 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Post Study Access of CSL312 (Garadacimab) for Pediatric Participants With Hereditary Angioedema Who Have Completed the CSL312_3003 Study

NCT07159464 ·Status: AVAILABLE

A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema

NCT06007677 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

NCT00289211 ·Status: COMPLETED ·Phase: PHASE3

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

NCT06960213 ·Status: RECRUITING ·Phase: PHASE3

Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

NCT06669754 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults

NCT04583007 ·Status: NO_LONGER_AVAILABLE

A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

NCT00912093 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

NCT02316353 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE

NCT01457430 ·Status: COMPLETED ·Phase: PHASE4

Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients

NCT07046806 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE

NCT03485911 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

NCT02586805 ·Status: COMPLETED ·Phase: PHASE3

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

NCT00262288 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema

NCT01832896 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor

NCT02247739 ·Status: COMPLETED ·Phase: PHASE2

A Study in Teenagers and Adults With Hereditary Angioedema (HAE) Type I or Type II Who Use Lanadelumab as Long-Term Prophylaxis

NCT04861090 ·Status: COMPLETED

A Long Term Safety Study of BCX7353 in Hereditary Angioedema

NCT03472040 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema

NCT05819775 ·Status: COMPLETED ·Phase: PHASE3